Stockscreener 앱 받기
207.98
2.35%
4.77
시간 외 거래:
207.98
전일 마감가:
$203.21
열려 있는:
$198.19
하루 거래량:
1.28M
Relative Volume:
1.10
시가총액:
$29.48B
수익:
$2.31B
순이익/손실:
$-208.16M
주가수익비율:
-135.35
EPS:
-1.5366
순현금흐름:
$76.11M
1주 성능:
+6.03%
1개월 성능:
+3.90%
6개월 성능:
+29.82%
1년 성능:
+45.24%
1일 변동 폭
$198.02
$210.99
1주일 범위
$181.00
$210.99
52주 변동 폭
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
207.98 | 29.48B | 2.31B | -208.16M | 76.11M | -1.5366 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Natera sec. and chief legal officer sells $307k in stock - Investing.com
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
Natera, Inc. $NTRA Shares Sold by SWS Partners - MarketBeat
Natera, Inc. Files Form 8-K Reporting Company Details and Regulatory Compliance as of March 26, 2026 - Minichart
Natera (NTRA) chair exercises 41,708 options, now holds 2.35M shares - Stock Titan
Natera Jumps After Exceeding Earnings Expectations and Unprecedented Institutional Purchases Even as Insiders Sell - bitget.com
Natera Expands Board, Appoints Eric Rubin as Director - TipRanks
Natera appoints Eric Rubin to board, expands board size to eleven members - Investing.com
Eric Rubin appointed to Natera board as Class I director - TradingView
Natera, Inc. Appoints Eric Rubin to the Board and Member of Nominating, Corporate Governance and Compliance Committee, Effective March 26, 2026 - MarketScreener
Eric Rubin joins Natera (NASDAQ: NTRA) board as independent director - Stock Titan
Solomon Moshkevich files Form 144; 3,000 Performance Shares (NTRA) - Stock Titan
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
J. Safra Sarasin Holding AG Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera (NTRA) - simplywall.st
Natera, Inc. $NTRA Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery - Benzinga
Avoiding Lag: Real-Time Signals in (NTRA) Movement - Stock Traders Daily
Natera, Inc. $NTRA Shares Sold by Zevenbergen Capital Investments LLC - MarketBeat
Why Natera Stock Is Surging Despite Recent Volatility - TipRanks
Blood test helped some women over 70 with breast cancer avoid surgery - Stock Titan
SG Americas Securities LLC Reduces Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas - MSN
Natera Inc (NTRA) Shares Down 6.88% on Mar 30 - GuruFocus
Is It Time To Reassess Natera (NTRA) After Recent Share Price Pullback - Yahoo Finance
Prenatal Testing Market Is Booming Rapidly with Strong Demand - openPR.com
Dakota Wealth Management Buys Shares of 5,921 Natera, Inc. $NTRA - MarketBeat
A Look At Natera (NTRA) Valuation After Recent Share Price Weakness - simplywall.st
DAVENPORT & Co LLC Takes Position in Natera, Inc. $NTRA - marketbeat.com
Natera, Inc. $NTRA Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Sentiment Review: What is the next catalyst for Natera IncCEO Change & Technical Entry and Exit Alerts - baoquankhu1.vn
Why Natera’s Stock Is Suddenly Sinking Hard - TipRanks
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - Yahoo Finance
Natera Inc (NTRA) Shares Down 4.14% on Mar 27 - GuruFocus
Vanguard disaggregates holdings; reports 0 shares for Natera (NTRA) - Stock Titan
Wealth Enhancement Advisory Services LLC Has $11.48 Million Stock Position in Natera, Inc. $NTRA - MarketBeat
Meme Stocks: Is now the right time to enter Natera Inc2026 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Natera Sees Relative Strength Rating Improve To 73 - investors.com
$8.25M Natera prenatal screening class action settlement - Class Action Lawsuits
Natera (NTRA) launches Zenith genomic assay - MSN
Is It Time To Reassess Natera (NTRA) After Its Recent Share Price Pullback - simplywall.st
If You Invested $1000 In Natera Stock 10 Years Ago, You Would Have This Much Today - Sahm
Natera (NTRA) Launches Zenith Genomic Assay - Insider Monkey
Systrade AG Buys Shares of 50,000 Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
DEEPWATER ASSET MANAGEMENT, LLC's Natera Inc(NTRA) Holding History - GuruFocus
Natera Inc (NTRA) Stock Price Up 2.86% on Mar 23 - GuruFocus
Natera, Inc.(NasdaqGS: NTRA) added to FTSE All-World Index - MarketScreener
Natera co-founder Jonathan Sheena sells shares worth $908,301 By Investing.com - Investing.com Canada
Natera co-founder Jonathan Sheena sells shares worth $908,301 - Investing.com UK
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
1.11%
자본화:
|
볼륨(24시간):